Eurofins Acquires the Discovery and Development Solutions Business of Merck KGaA - - BioPharm International

ADVERTISEMENT

Eurofins Acquires the Discovery and Development Solutions Business of Merck KGaA



Eurofins Scientific has signed an agreement to acquire the assets of the Discovery and Development Solutions (DDS) business of Merck Millipore (EMD Millipore in the United States and Canada), the Life Science division of Merck KGaA, Darmstadt, Germany. DDS is a provider of bioanalytical testing and early stage discovery services and products to the biopharmaceutical market. DDS generates revenues of about $35 million with 175 employees from its three sites in Missouri, Scotland, and England.

In addition, DDS provides expertise in bioanalytical testing to support clinical trials. The acquisition of DDS will strengthen Eurofins' presence in the early stage discovery solutions market while adding expertise in high-quality bioanalytical services, according to the company. After the transaction, DDS will continue to provide products and services to Merck KGaA's pharma business.

As part of the agreement, DDS will continue to be led by Christina Shasserre, who has headed the DDS business since 2010. Shasserre will become president of Eurofins Pharma BioAnalytical Services, as the company will be renamed following the closing. The transaction is subject to standard closing conditions, which the parties expect to complete within 90 days.

Source: Eurofins Scientific
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Lilly to Acquire Novartis Animal Health
April 22, 2014
Novartis and GSK Trade Assets
April 22, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
EMA Warns of Falsified Herceptin Vials
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Author Guidelines

Click here